BOTOX Cosmetic

Name

BOTOX Cosmetic

Legal name

BOTOX Cosmetic (Product Brand owned by Allergan Aesthetics, a subsidiary of AbbVie Inc.)

Website

https://botoxcosmetic.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Aesthetic Neurotoxin Injectables

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Medicinal and Botanical Manufacturing (325411)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)

Keywords

• Prescription injectable treatment
• Botulinum toxin aesthetic
• Facial line treatment
• Aesthetic neurotoxin injectables
• Cosmetic injectable pharmaceuticals

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Operations, Technology or R&D, Personnel, Supply Chain, Infrastructure

Revenue model

1. Prescription Injectable Sales: BOTOX Cosmetic is sold as a prescription medicine to licensed medical providers who then administer treatments to patients. The product is a prescription injectable that providers purchase and administer to consumers seeking treatment for facial lines.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

BOTOX Cosmetic (onabotulinumtoxinA) is a prescription injectable treatment that temporarily reduces underlying muscle activity to improve the appearance of moderate to severe frown lines, crow's feet, forehead lines, and vertical bands connecting the neck and jaw (platysma bands) in adults. The product is manufactured using a proprietary process and administered by licensed medical specialists in 10–15 minute sessions with minimal downtime, with results visible in 24–48 hours and full results within 14–30 days.

Product overview

BOTOX Cosmetic is a single prescription injectable medication (onabotulinumtoxinA) that is the original and only FDA-approved product of its kind for over 20 years. The core product is supplemented by The Look of 3® treatment protocol (a 64-unit, 3-area treatment plan), the Allē loyalty program for patient rewards and savings, and The Confidence Collective initiative supporting women entrepreneurs. The main product treats four areas: forehead lines, frown lines, crow's feet, and vertical bands connecting the neck and jaw.

Differentiator

Problem solved

Functional benefit

Brands

• Allē: The leading aesthetics loyalty program in the US, by the makers of BOTOX Cosmetic. Allows members to earn points on BOTOX Cosmetic treatments and over 50 other products and treatments, redeemable for savings on qualifying injectables and Skinmedica products.

Products and services

• BOTOX® Cosmetic (onabotulinumtoxinA) A prescription injectable treatment that temporarily reduces underlying muscle activity to improve the appearance of moderate to severe frown lines, crow's feet, forehead lines, and vertical bands connecting the neck and jaw (platysma bands) in adults. Administered by licensed medical specialists in 10-15 minute in-office sessions with minimal downtime; results visible in 24-48 hours, full results in 14-30 days, lasting up to 4 months.
• The Look of 3® A trademarked treatment protocol involving 64 units of BOTOX Cosmetic administered across three areas: 20 units for frown lines, 24 units for crow's feet (12 on each side), and 20 units for forehead lines. Treatments should be spaced at least 90 days apart and are intended for administration at least three times per year.
• Allē (Aesthetics Loyalty Program) A consumer loyalty program and provider directory mobile app (iOS and Google Play) that lets patients earn points on BOTOX Cosmetic treatments and over 50 other eligible products/services, redeemable for savings on qualifying aesthetic treatments. Includes exclusive member events like BOTOX Cosmetic Day and seasonal double-points offers.

Quantifiable outcome

• 61% and 46% of patients had ≥2-grade improvement at Day 30 for forehead lines
• +5 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• Hello AliceflagshipStrategic or Co-development PartnerHello Alice is a partner in The Confidence Collective initiative, a program by BOTOX Cosmetic that empowers women entrepreneurs. Through this partnership, 250 women entrepreneurs receive personalized mentorship and expert-led training through Boost Camp, a hands-on virtual accelerator. Hello Alice facilitates skill development in finance, marketing, leadership, and digital strategy.
• CherrycoreTechnology or IntegrationCherry provides the payment plan technology powering Allē Payment Plans, allowing patients to get treated now and pay over time in flexible monthly installments. No hard credit checks and no hidden fees. Cherry Technologies, Inc. issues these payment options through its lending partners.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Xeomin (incobotulinumtoxinA): Merz Aesthetics' botulinum toxin type A injectable competing in the same facial aesthetic indications as BOTOX Cosmetic, marketed on a purified formulation without accessory proteins.
• Daxxify (daxibotulinumtoxinA-lanm): Revance Therapeutics' longer-duration botulinum toxin competing on duration-of-effect claims, targeting the same aesthetic provider channel and indications as BOTOX Cosmetic.
• Letybo (letibotulinumtoxinA): Hugel's botulinum toxin type A recently entering the US aesthetics market, competing on price and indication parity with BOTOX Cosmetic across glabellar and crow's feet lines.
• Dysport (abobotulinumtoxinA): Galderma's (formerly Ipsen) competing botulinum toxin type A injectable approved for aesthetic use, directly competing with BOTOX Cosmetic in frown lines and crow's feet indications with similar mechanism and provider channel.
• Jeuveau (prabotulinumtoxinA): Evolus's 'Newtox' aesthetic-only botulinum toxin directly targeting BOTOX Cosmetic's cosmetic indications at a competitive price point, primarily through the medical aesthetics provider channel.

Broad incumbents

• Sculptra: Galderma's PLLA collagen biostimulator operating in the same facial aesthetics provider channel as BOTOX Cosmetic, addressing aging facial volume rather than dynamic lines.
• Juvederm: Allergan Aesthetics' hyaluronic acid dermal filler portfolio — a sister brand under the same AbbVie/Allergan Aesthetics umbrella — competing in the broader facial aesthetics category that BOTOX Cosmetic operates in.
• Radiesse: Merz Aesthetics' CaHA-based filler and biostimulator serving the same provider channel and facial aesthetic patient base as BOTOX Cosmetic, often positioned as a complementary or alternative treatment.
• Restylane: Galderma's HA filler portfolio competing for the same provider channel and aesthetic patient base as BOTOX Cosmetic, often used adjunctively with neurotoxins in facial rejuvenation.

Others

• SkinMedica: Allergan Aesthetics' professional skincare brand — a sister brand under the same parent — that participates in the Allē loyalty ecosystem alongside BOTOX Cosmetic and serves the same aesthetic patient demographic.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCgll6aLdtF8G83eNjSYkTaw
• Xx.com/BotoxCosmetic
• Facebookfacebook.com/BotoxCosmetic
• LinkedInlinkedin.com/company/botox-cosmetic

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BOTOX Cosmetic